CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Open-market sale Director sold 6,937 shares at $88.17 ($611,635)
- 4 Open-market sale Director sold 9,000 shares at $89.05 ($801,450)
- 4 Open-market sale HEAD OF R&D, COO-NOVITIUM OPS sold 100,000 shares at an average $88.25 ($8,824,533)
- 4 Open-market sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $86.97 ($1,739,400)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, HEAD - ESTABLISHED BRANDS sold 4,975 shares at $85.71 ($426,407)
- 4 Open-market sale PRESIDENT & CEO sold 56,960 shares at $85.93 ($4,894,573)
- 4 Open-market sale SVP, GENERICS sold 5,873 shares at $86.53 ($508,191)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $88.87 ($35,548)
- 4 Open-market sale SVP & CFO sold 50,000 shares at $86.07 ($4,303,500)
- 4 Open-market sale Director sold 19,341 shares at $85.93 ($1,661,972)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 90 · 1,784 filings